Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9016305 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2005 | 16 Pages |
Abstract
The Hypothesis of Initial Conditions posits that differences in psychotropic drug response result from individual differences in receptor site kinetics, and differences in the sensitivity of downstream receptor-linked responses. This work examines data consistent with the hypothesis, specific to genetic and kinetic differences of the serotonin (5-HT) transporter (SERT), as they may be linked to divergent antidepressant response (ADR). The mechanisms for divergent ADR in association with different initial SERT function are considered within the context of SERT trafficking as sensitive to various different kinase and cytokine signals, some of which are dependent on the 5-HTTLPR polymorphism of the SERT gene. Pilot data suggest that human lymphocytes show kinase changes similar to those found in rat brain with ADT. These studies additionally suggest that ADT prompts a shift in cytokine gene expression toward a greater anti-inflammatory/inflammatory ratio. These latter findings are discussed within the context of a literature suggesting increased inflammatory cytokine levels in depression, and recent observations of increased temperature associated with depression. In sum, the data suggest the opportunity to identify response dependent protein (RDP) expression patterns that may differ with dichotomous ADR, and suggest new insights into understanding the mechanisms of psychotropic drug response through an understanding of initial differences in potential for psychotropic drug target regulation during therapy.
Keywords
5-HTTLPRpKaJAK1ADTSAPKRT-PCRADRRDPSSRIsinterleukin receptor-associated kinasePKC5-HTJanus kinasecAMPNa+Adenosine TriphosphateATPCyclic adenosine monophosphatestress activated protein kinaseribonucleic acidRNADepressioninterleukin5-HT uptakeAntidepressantsAntidepressant treatmentSERTSodiumSerotoninserotonin transporterCytokineInitial conditionsIRAKLymphocyteselective serotonin reuptake inhibitorsHPAhypothalamic-pituitary-adrenalReverse transcriptase-polymerase chain reactionAntidepressant responsePotassiumprotein kinase AProtein kinase CPlateletKinaseIce
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Jeffrey L. Rausch,